On 23rd September 2021, Nazende Günday-Türeli, MyBiotech GmbH, will present the “PHOENIX Open Innovation Test Bed for GMP Manufacturing of Nanopharmaceuticals” at the workshop “MEET OUR INDUSTRY PARTNERS”, organised by the COST Action NANO2CLINIC (CA17140).
NANO2CLINIC is the first pan-European interdisciplinary network of representatives from academic institutions and SMEs including clinical research organizations (CROs) devoted to the development of nanosystems carrying anticancer drugs from their initial design, pre-clinical testing of efficacy, pharmacokinetics and toxicity to the preparation of detailed protocols needed for the first phase of their clinical studies